Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 08, 2018 08:00 ET | Source: Teligent, Inc.

Teligent, Inc. Announces First Quarter 2018 Results

BUENA, N.J., May 08, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter...
May 07, 2018 18:36 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday, May 8, 2018

BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care...
May 07, 2018 17:50 ET | Source: Teligent, Inc.

Teligent, Inc. to Reschedule Conference Call for First Quarter 2018 Results

BUENA, N.J., May 07, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, initially announced the Company would hold a conference call...
May 01, 2018 16:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at Deutsche Bank’s 43rd Annual Health Care Conference on Tuesday May 8, 2018

BUENA, N.J., May 01, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Deutsche Bank’s 43rd Annual Health Care...
April 27, 2018 09:25 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Agreements to Exchange Approximately $65 million of its 3.75% Senior Convertible Notes Due 2019 for 4.75% Senior Convertible Notes Due 2023

BUENA, N.J., April 27, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT) (“Teligent”) announced today that it has entered into separate, privately negotiated exchange agreements with certain...
April 26, 2018 14:15 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for First Quarter 2018 Results

BUENA, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
April 17, 2018 16:35 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%

BUENA, N.J., April 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
April 06, 2018 10:32 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Ciclopirox Shampoo, 1%

BUENA, N.J., April 06, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
March 21, 2018 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Halobetasol Propionate Ointment, 0.05%

BUENA, N.J., March 21, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
March 15, 2018 16:10 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Fourth Quarter and Year End 2017 Results

BUENA, N.J., March 15, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the fourth...